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Abstract The mechanisms involved in the development of
wound metastasis following laparoscopic abdominal tumor
surgery remain unclear. The aim of this study was to accurate-
ly assess whether the duration of carbon dioxide pneumoperi-
toneum (CDP) during laparoscopic abdominal tumor surgery
enhances wound metastases. We conducted a systematic re-
view of PubMed, Cochrane Library, and Embase through
December 2013 to identify animal experiments comparing
wound recurrence between laparoscopic and gasless laparo-
scopic procedures or open procedures. The outcome of inter-
est was the number of animals with a wound tumor. Meta-
regression was used to assess whether heterogeneity was
explained by study level covariates (animal model, study size,
CDP pressure, duration, and evaluated time). Twenty random-
ized control studies involving 1,229 animals were included.
Wound recurrence was not significant in the laparoscopic
surgery (LP) vs. gasless laparoscopic surgery (GLP) sub-
groups [odds ratio (OR), 2.23; 95 % confidence interval
(CI), 0.90–5.55; P=0.08) or the LP vs. laparotomy (LA)
subgroups (OR, 0.97; 95 % CI, 0.31–3.00; P=0.08). Overall
postoperative wound recurrence results were not significantly
different between the study groups and controls (OR, 1.47;
95 % CI, 0.74–2.92; P=0.28). A meta-regression analysis
showed that the outcome was not correlated with the
covariates (animal model: P=0.82; evaluated time: P=0.30;
pressure of CDP: P=0.12; duration time: P=0.80). Current
evidence suggests that CDP does not enhance wound metas-
tases following laparoscopic abdominal tumor surgery. Addi-
tional large sample, well-designed, randomized, controlled
trials are needed to further confirm whether CDP duration in
laparoscopic abdominal tumor surgery significantly enhances
wound recurrence.
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Introduction
The advantages of laparoscopic surgery, including quicker
recovery time, less pain, and shorter hospital stay, are evident
in patients with intra-abdominal malignancies [1–4]. Howev-
er, this technology has limited application for concerns about
wound (port-site) metastases following laparoscopic abdomi-
nal tumor surgery. Wound metastases following a laparoscop-
ic procedure were first found in a patient with ovarian cancer
who underwent abdominoscopy in 1978 [5], and other reports
quickly followed. Wound metastases have been found in
many types of intra-abdominal malignancies, such as cancers
of the genitourinary system, kidney, colon, stomach, and
gallbladder during laparoscopic procedures [6–10].
Carbon dioxide pneumoperitoneum (CDP) has been wide-
ly used during laparoscopic abdominal surgery to establish
optimal visualization of the operative field; however, whether
it enhances wound recurrence remains unclear. To date, con-
flicting results have been published about the effects of CDP
on wound metastases. Some randomized control trials (RCTs)
have reported that the duration of intraoperative CDP en-
hances wound metastasis. For example, Hopkins et al. and
Mathew et al. regarded CDP as the direct cause of tumor
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spread and implantation [11, 12], but several other RCTs
reported that CDP has no effect on wound recurrence. Mutter
et al. suggested that manipulation is the major cause for
wound recurrence following laparoscopic abdominal tumor
surgery [13], and Gutt et al. suggested that both laparotomy
incision and surgical manipulation stimulate local tumor
spread more than does CDP [14]. Several reviews have con-
cluded that the etiology for wound metastasis following ab-
dominal tumor surgery is not yet understood [15–17] since a
number of factors (i.e., CDP, aerosolization, chimney effect,
immune response, and surgical technique) are involved. Thus,
whether CDP duration enhances wound metastasis remains
unclear. Therefore, it is necessary to reassess all data and
elucidate controversial or inconclusive results. We assumed
that the duration of CDP enhanced wound recurrence follow-




The PubMed, Embase, and Cochrane Library electronic data-
bases were used to search for animal studies up to December
2013. The followingmedical subject heading terms and words
were used, in all possible combinations, for the search: “pneu-
moperitoneum,” “insufflation,” “neoplasm metastasis,” “me-
tastasis,” “recurrence,” “port side,” “trocar side,”“wound,”
and “incision”. A filter for identifying comparable studies
recommended by the Cochrane Collaboration was used to
filter out randomized studies in PubMed and Embase [18].
A manual search of the reference lists of relevant articles was
performed. No language or time restrictions were made.
Eligibility criteria
We included a study in the analysis if it met the following
criteria: (1) study design: RCT; (2) population: animals un-
dergoing laparoscopic abdominal tumor procedures; (3) inter-
vention: duration of CDP during the intraoperative period; (4)
comparison group: animals undergoing gasless laparoscopic
abdominal surgery or animals undergoing open abdominal
tumor surgery; and (5) all studies included had to have report-
ed the number of animals with wound tumors. Wound
metastasis/recurrence was defined as the number of animals
that developed at least one wound with tumor implantation
after a laparoscopic or open procedure.We excluded a study if
it met any of the following criteria: (1) a design other than
RCT; (2) the outcome was not that of the number of animals
with a wound tumor; (3) intervention other than CDP dura-
tion; and (4) inability to extract the raw data and failure to
obtain the data from the authors.
Data extraction
Data were carefully extracted from all eligible publications by
two investigators (Xianwei Mo and Yang Yang) independent-
ly, according to the above inclusion criteria. Any disagree-
ments were resolved by discussionwith a third reviewer (Yuan
Lin) during a consensus meeting. The data extracted included
the first author’s last name, publication year, study design,
country, animal model, number of animals, tumor cell line,
postoperative evaluation date, length of incisions, pneumo-
peritoneum pressure, and duration.
Assessment of study quality
We used the method described by Sun et al. to evaluate the
quality of the involved studies [19]. The study quality was
rated using the following six criteria [20, 21]: (I) peer-
reviewed publication (score of 2); (II) random allocation to
treatment or control (score of 2); (III) animal species (inbred
strain, age-matched, statement ofMHCmismatch, score of 2);
(IV) sample size (sample sizes of both the control and exper-
imental groups must be clearly defined; score of 1); (V)
animal welfare regulations were observed (score of 1); and
(VI) statement of potential conflict of interests (funding
sources must be clearly stated; score of 1). If information
was incomplete for any criterion, half of the corresponding
score was assigned. Study quality was stratified into four
ranks according to their scores: A (score of 7–9); B (score of
5–6); C (score of 3–4); and D (score of 0–2). Two authors
(Xianwei Mo and Yang Yang) evaluated the quality of the
studies independently. Discrepancies were resolved by
consensus.
Statistical analysis
Data were analyzed using STATA ver. 12.0 (StataCorp LP,
College Station, TX, USA). The statistical analysis for dichot-
omous variables was performed using the odds ratio (OR) and
a random- or fixed-effects model according to the presence or
absence of heterogeneity. We used theQ-based chi-square test
and the I2 statistic to assess heterogeneity among studies, with
a P value <0.10 representing statistical significance. Sensitiv-
ity and subgroup analyses were used to explore potential
causes of heterogeneity. Subgroup analyses were performed
to examine whether the number of animals with wound recur-
rence varied by CDP duration regardless of whether it was a
laparoscopic procedure or another type of surgery (laparo-
scopic or open surgery). A meta-regression model was used
to assess whether heterogeneity was explained by study level
covariates (animal model, study size, CDP pressure, duration,
and evaluated time).
7352 Tumor Biol. (2014) 35:7351–7359
Results
Literature search
Figure 1 depicts the PRISMA flow chart for study inclusion
and exclusion criteria. A total of 197 records were retrieved
from the database search, and 13 records were identified
through a manual search of the reference lists of relevant
articles. After removing duplicate results, 189 records
remained. Of these, 28 studies were selected for full-text
examination. Nine were excluded for the following reasons:
raw data could not be extracted in the appropriate format (n=
7) [12, 22–27], and the comparison group was not of interest
(n=1) [28]. Ultimately, 20 studies fulfilled the inclusion
criteria for our meta-analysis [11, 14, 29–46].
Study characteristics
Table 1 shows the characteristics of all studies. The studies
were published between 1995 and 2003. The design of all
studies was RCT. One study was conducted in Belgium [44],
nine in the USA [11, 29–31, 33, 34, 38, 40, 41], four in
Australia [32, 36, 37, 46], one in the UK [42], two in France
[35, 45], one in Japan [39], one in Germany [14], and one in
Israel [43]. A total of 597 animals were included in the study
groups and 632 were controls. The most common animal
model was the rat [11, 14, 29, 30, 32, 33, 35–37, 42,
44–46], while others included rabbits [39, 41], mice [31, 40,
43], or hamsters [34, 38]. The type of gas used in all studies
was carbon dioxide. CDP pressure ranged from 2 to 10mmHg
in the experimental groups and the duration was from 15 min
to 2 h. In most of the animal experiments, the sample size was
small (<30) [11, 14, 32, 35–37, 39, 41–46], and the follow-up
date was short (<4 weeks) [11, 14, 29–32, 36, 37, 39–41, 43,
45, 46]. Eight studies included three group dates and were
divided into two groups of comparative dates to allow for a
pooled analysis of the outcomes [11, 14, 32, 34, 35, 39, 42,
45]. Fourteen studies described the length of incisions [20, 30,
33, 46–56]. The length of incision was the same in the study
and control groups in six studies [20, 48, 52, 53, 55, 57],
whereas the length of incision was much shorter in the study
group than the control in the other eight studies (Table 1) [30,
33, 46, 47, 50, 51, 54, 56].
Quality assessment of the included studies
The quality scores for the studies ranged from 6 to 8, with 10
studies ranked as A [11, 29, 30, 33, 34, 36–38, 45, 46], 10 as B
[14, 31, 32, 35, 39–44], and none as C or D (Table 2). The
quality was high (A) in half of the studies.
Quantitative synthesis of data
Wound recurrence (Fig. 2) was not significant in the laparo-
scopic surgery (LP) vs. gasless laparoscopic surgery (GLP)
subgroups [OR, 2.23; 95 % confidence interval (CI), 0.90–
Fig. 1 Flow chart for the
systematic search and study
selection strategy
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5.55; P=0.08], and the LP vs. laparotomy (LA) subgroups
showed consistent results (OR, 0.97; 95 % CI, 0.3–3.00; P=
0.08). The overall pooled estimate results showed that wound
recurrence was not significant between the study groups and
controls (OR, 1.47; 95 % CI, 0.74–2.92; P=0.28). Evidence
of significant heterogeneity was seen across trials in the above
analysis (I2=76.2 % and PQ=0.00 for heterogeneity). A meta-
regression analysis showed that the number of animals with
wound tumors was not correlated with the covariates (animal
model: P=0.82; evaluated time: P=0.30; CDP pressure: P=
0.12; duration: P=0.80).
Sensitivity analysis
The inclusion criteria of this meta-analysis were subjected to a
sensitivity analysis to determine whether modifying inclusion
criteria affected the results. A single study involved in the
meta-analysis was deleted each time to reflect the influence of
each individual dataset on the pooled OR. The corresponding
pooled OR was essentially unaltered (data not shown), indi-
cating that our results were statistically sound.
Risk of publication bias
Publication bias was assessed by Begg’s funnel plots and
Egger’s tests. The shapes of the Begg’s funnel plots revealed
no obvious asymmetry (Fig. 3). The Egger’s test was then
used to statistically assess funnel plot symmetry. The funnel
plot was relatively symmetrical, suggesting no publication
bias (t=1.16, P=0.26 for the number of animals with a wound
tumor). This indicates that the results of these meta-analyses
were relatively stable and were unlikely to have been affected
by publication bias.
Discussion
The association between CDP duration during laparoscopic
abdominal tumor surgery and wound recurrence is not fully
understood. Animal experiments comparing implantation of
wound tumors between laparoscopy and laparotomy have
presented conflicting results. Several studies have suggested
that wound recurrence was not significantly different between
laparoscopy and other procedures (gasless laparoscopic sur-
gery or open surgery) [14, 29, 31, 32, 34, 36–43], whereas
others have suggested that wound recurrence may have been
caused directly by CDP [11, 12, 32]. However, sample size
was small in these studies, and they were not individually
powered to detect small differences in outcomes. A pooled
synthesis of these studies may provide further insight into the
results. Our meta-analysis of 20 random control studies pro-
vides evidence that CDP duration in laparoscopic abdominal
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Fig. 2 Forest plots of number of animals with wound tumor in subgroup analysis using a random-effect model
Fig. 3 Funnel plot analysis to
detect publication bias; each point
represents a separate study for the
indicated association
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The underlying mechanism involved in tumor cell wound
implantation is uncertain. One possible explanation is trocar
use or CDP [11]. Other explanations are the chimney effect,
immune response, aerosolization, and poor surgical technique
[58]. Thus, the exact mechanism for the development of
wound metastases is not yet known, and current evidence
shows that CDP is not responsible for these tumors. It seems
that the mechanisms are multimodal. Whatever the reason, it
is advised that laparoscopic tumor surgery be performed by
adequately trained and experienced surgeons and that strict
oncologic techniques should be followed.
The interpretation of the results may have been affected by
heterogeneity. Large heterogeneity was observed among stud-
ies. We performed a sensitivity analysis on these subgroup
analyses. A study by Jones et al. with LP vs. GLP subgroups
revealed more animals with wound recurrence in the study
group than those in the control [38]. Dropping this study did
not yield opposite results in the number of animals with
wound recurrence, but large heterogeneity remained (I2=
72.4 %). The sensitivity analysis showed that the study by
Paik et al. had a large impact on our results [29], as dropping
this study yielded opposite findings for the number of animals
with wound recurrence (OR, 2.77; 95 % CI, 1.13–6.84, P=
0.03). For the LP vs. LA subgroup, more wound recurrence
animals were found in the study group than in controls in
Mathew et al. (group 2) [32]. Dropping this study did not yield
opposite results, and large heterogeneity was still present (I2=
75.7 %). A sensitivity analysis of this subgroup showed that
the study by Lee et al. had a large impact on our results [53],
and an opposite finding did not occur after dropping this
study.
The conflicting results of the studies in our meta-analysis
may have been due to (1) the small number of cases in some
studies, which increased the possibility that chance accounted
for their results; (2) the animal model, CDP pressure, opera-
tive time, and tumor cell line in the studies were not uniform,
and the follow-up date was short; and (3) several factors, such
as trocar placement [39] and peritoneal closure, may have
contributed to wound metastasis [59]. These factors in the
LP groups were also not uniform.
We included different animal models to evaluate wound
recurrence following laparoscopic abdominal tumor surgery
and then performed a subgroup analysis based on the variation
in wound recurrence with CDP duration, regardless of wheth-
er a laparoscopic procedure or another type of surgery (lapa-
roscopic or open surgery) was used. There was sufficient
evidence in the 20 randomized control studies to conclude
that CDP duration does not enhance wound recurrence fol-
lowing laparoscopic abdominal tumor surgery. This may be
the first meta-analysis in which the relationship between CDP
duration and wound recurrence has been evaluated systemat-
ically. With the accumulating evidence and enlarged sample
size, the statistical power to provide more precise and reliable
efficiency estimates was enhanced despite the variations in the
results from each study. Overall, the published evidence did
not support the assumption that CDP duration enhances
wound recurrence.
Our meta-analysis had several limitations. First, the animal
model, CDP pressure, operative time, and tumor cell lines in
the studies were not uniform (Table 1), leading to potential
bias in our analysis. Second, several studies had small sample
sizes, and follow-up duration was short. It is possible that the
lack of a significant difference in the number of animals with
port-site tumors between the LP group and other groups was
due to these factors. Therefore, large-scale, well-designed
trials focusing on different types of animal models are re-
quired to establish whether CDP duration enhances wound
recurrence. Third, there is no standard tool to evaluate the
quality of an animal experiment in a meta-analysis. Jada
Queries or Cochrane tools are the most commonly used power
tools for this purpose; however, the subjects in those studies
were humans. In our meta-analysis, the subjects were animals,
so they did not follow the assessment methods in the Jada
Queries or Cochrane tools guidelines, such as “double
blinding.” We used the method described by Sun et al. to
evaluate the study quality [19], which may have produced
bias. Four, substantial heterogeneity was present among the
studies. Bias was potentially produced by several uncontrolled
factors, such as the effects of trocar placement, peritoneal
closure, and tumor manipulation [58].
Conclusions
Current evidence suggests that CDP does not enhance wound
metastases following laparoscopic abdominal tumor surgery.
Additional large sample, well-designed, randomized, con-
trolled trials are needed to further confirm whether CDP
duration during laparoscopic abdominal tumor surgery signif-
icantly enhances wound recurrence.
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